Assessment of neuroprotection in the retina with DARC

Progress in Brain Research

Volumn 173, Issue , 2008, Pages 437-450

  Guo, Li ^a   Cordeiro, M Francesca ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b WESTERN EYE HOSPITAL   (United Kingdom)

Author keywords

coenzyme Q10; DARC; glaucoma; glutamate modulation; neuroprotection; RGC apoptosis; targeting A pathway

Indexed keywords

AMYLOID BETA PROTEIN; DIZOCILPINE; EGLUMETAD; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; IFENPRODIL; LIPOCORTIN 5; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UBIDECARENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BLINDNESS; DETECTION OF APOPTOSING RETINAL CELLS TECHNIQUE; EXCITOTOXICITY; GLAUCOMA; IMAGING SYSTEM; NEUROPROTECTION; NON INVASIVE PROCEDURE; NONHUMAN; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PERIMETRY; PRIORITY JOURNAL; RAT; RETINA; RETINA GANGLION CELL; REVIEW; SCREENING; VISUAL FIELD DEFECT;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; GLAUCOMA; GLUTAMIC ACID; HUMANS; LASERS; NEUROPROTECTIVE AGENTS; OPHTHALMOSCOPES; OPHTHALMOSCOPY; PERIMETRY; RETINAL GANGLION CELLS; UBIQUINONE; VISUAL FIELDS; VITAMINS;

EID: 53049102476     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)01130-8     Document Type: Review

References (109)

1. Archer S., Hirano J., Diss J.K., Fraser S.P., and Djamgoz M.B. Expression and localization in the fish retina of a homologue of the Alzheimer's related PS1 gene. Neuroreport 9 9 (1998) 2049-2056
2. Auld D.S., Kornecook T.J., Bastianetto S., and Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog. Neurobiol. 68 3 (2002) 209-245
3. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk D., and Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6 8 (2000) 916-919
4. Bayer A.U., Keller O.N., Ferrari F., and Maag K.P. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am. J. Ophthalmol. 133 1 (2002) 135-137
5. Belmokhtar C.A., Hillion J., and Segal-Bendirdjian E. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 20 26 (2001) 3354-3362
6. Berisha F., Feke G.T., Trempe C.L., McMeel J.W., and Schepens C.L. Retinal abnormalities in early Alzheimer's disease. Invest. Ophthalmol. Vis. Sci. 48 5 (2007) 2285-2289
7. Blankenberg F.G., Katsikis P.D., Tait J.F., Davis R.E., Naumovski L., Ohtsuki K., Kopiwoda S., Abrams M.J., Darkes M., Robbins R.C., Maecker H.T., and Strauss H.W. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl. Acad. Sci. U.S.A. 95 11 (1998) 6349-6354
8. Blanks J.C., Schmidt S.Y., Torigoe Y., Porrello K.V., Hinton D.R., and Blanks R.H. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol. Aging 17 3 (1996) 385-395
9. Blanks J.C., Torigoe Y., Hinton D.R., and Blanks R.H. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol. Aging 17 3 (1996) 377-384
10. Boersma H.H., Liem I.H., Kemerink G.J., Thimister P.W., Hofstra L., Stolk L.M., van Heerde W.L., Pakbiers M.T., Janssen D., Beysens A.J., Reutelingsperger C.P., and Heidendal G.A. Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5. Br. J. Radiol. 76 908 (2003) 553-560
11. Bond A., O'Neill M.J., Hicks C.A., Monn J.A., and Lodge D. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. Neuroreport 9 6 (1998) 1191-1193
12. Brandstatter J.H., Hartveit E., Sassoe-Pognetto M., and Wassle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur. J. Neurosci. 6 7 (1994) 1100-1112
13. Brooks D.E., Garcia G.A., Dreyer E.B., Zurakowski D., and Franco-Bourland R.E. Vitreous body glutamate concentration in dogs with glaucoma. Am. J. Vet. Res. 58 8 (1997) 864-867
14. Carter-Dawson L., Crawford M.L., Harwerth R.S., Smith III E.L., Feldman R., Shen F.F., Mitchell C.K., and Whitetree A. Vitreal glutamate concentration in monkeys with experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 43 8 (2002) 2633-2637
15. Chaudhary P., Ahmed F., and Sharma S.C. MK801 - a neuroprotectant in rat hypertensive eyes. Brain Res. 792 1 (1998) 154-158
16. Citron M. Beta-secretase as a target for the treatment of Alzheimer's disease. J. Neurosci. Res. 70 3 (2002) 373-379
17. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am. J. Ophthalmol. 126 4 (1998) 487-497
18. Cordeiro M.F., Guo L., Cheung W., Wood N., and Salt T.E. Topical CoQ10 Is Neuroprotective in Experimental Glaucoma (2007), ARVO, Fort Lauderdale, USA
19. Cordeiro M.F., Guo L., Luong V., Harding G., Wang W., Jones H.E., Moss S.E., Sillito A.M., and Fitzke F.W. Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 101 36 (2004) 13352-13356
20. Danesh-Meyer H.V., Carroll S.C., Ku J.Y., Hsiang J., Gaskin B., Gamble G.G., and Savino P.J. Correlation of retinal nerve fiber layer measured by scanning laser polarimeter to visual field in ischemic optic neuropathy. Arch. Ophthalmol. 124 12 (2006) 1720-1726
21. Dkhissi O., Chanut E., Wasowicz M., Savoldelli M., Nguyen-Legros J., Minvielle F., and Versaux-Botteri C. Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest. Ophthalmol. Vis. Sci. 40 5 (1999) 990-995
22. Dreyer E.B., Zurakowski D., Schumer R.A., Podos S.M., and Lipton S.A. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch. Ophthalmol. 114 3 (1996) 299-305
23. Dumont E.A., Hofstra L., van Heerde W.L., van den Eijnde S., Doevendans P.A., DeMuinck E., Daemen M.A., Smits J.F., Frederik P., Wellens H.J., Daemen M.J., and Reutelingsperger C.P. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation 102 13 (2000) 1564-1568
24. Dumont E.A., Reutelingsperger C.P., Smits J.F., Daemen M.J., Doevendans P.A., Wellens H.J., and Hofstra L. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat. Med. 7 12 (2001) 1352-1355
25. el-Asrar A.M., Morse P.H., Maimone D., Torczynski E., and Reder A.T. MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. Invest. Ophthalmol. Vis. Sci. 33 12 (1992) 3463-3468
26. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., and Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148 7 (1992) 2207-2216
27. Fitzke F. Imaging the optic nerve and ganglion cell layer. Eye 14 (2000) 450-453
28. Fletcher E.L., Hack I., Brandstatter J.H., and Wassle H. Synaptic localization of NMDA receptor subunits in the rat retina. J. Comp. Neurol. 420 1 (2000) 98-112
29. Goldblum D., Kipfer-Kauer A., Sarra G.M., Wolf S., and Frueh B.E. Distribution of amyloid precursor protein and amyloid-{beta} immunoreactivity in DBA/2J glaucomatous mouse retinas. Invest. Ophthalmol. Vis. Sci. 48 11 (2007) 5085-5090
30. Greenfield D.S., Girkin C., and Kwon Y.H. Memantine and progressive glaucoma. J. Glaucoma 14 1 (2005) 84-86
31. Guo L., Moss S.E., Alexander R.A., Ali R.R., Fitzke F.W., and Cordeiro M.F. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest. Ophthalmol. Vis. Sci. 46 1 (2005) 175-182
32. Guo L., Tsatourian V., Luong V., Podoleanu A.G., Jackson D.A., Fitzke F.W., and Cordeiro M.F. En face optical coherence tomography: a new method to analyse structural changes of the optic nerve head in rat glaucoma. Br. J. Ophthalmol. 89 9 (2005) 1210-1216
33. Guo L., Salt T.E., Maass A., Luong V., Moss S.E., Fitzke F.W., and Cordeiro M.F. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Invest. Ophthalmol. Vis. Sci. 47 2 (2006) 626-633
34. Guo L., Salt T.E., Luong V., Wood N., Cheung W., Maass A., Ferrari G., Russo-Marie F., Sillito A.M., Cheetham M.E., Moss S.E., Fitzke F.W., and Cordeiro M.F. Targeting amyloid-beta in glaucoma treatment. Proc. Natl. Acad. Sci. U.S.A. 104 33 (2007) 13444-13449
35. Hamassaki-Britto D.E., Hermans-Borgmeyer I., Heinemann S., and Hughes T.E. Expression of glutamate receptor genes in the mammalian retina: the localization of GluR1 through GluR7 mRNAs. J. Neurosci. 13 5 (1993) 1888-1898
36. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 5580 (2002) 353-356
37. Hare W.A., WoldeMussie E., Lai R.K., Ton H., Ruiz G., Chun T., and Wheeler L. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures. Invest. Ophthalmol. Vis. Sci. 45 8 (2004) 2625-2639
38. Hare W.A., WoldeMussie E., Weinreb R.N., Ton H., Ruiz G., Wijono M., Feldmann B., Zangwill L., and Wheeler L. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures. Invest. Ophthalmol. Vis. Sci. 45 8 (2004) 2640-2651
39. Hartveit E., Brandstatter J.H., Enz R., and Wassle H. Expression of the mRNA of seven metabotropic glutamate receptors (mGluR1 to 7) in the rat retina. An in situ hybridization study on tissue sections and isolated cells. Eur. J. Neurosci. 7 7 (1995) 1472-1483
40. Hartwick A.T., Zhang X., Chauhan B.C., and Baldridge W.H. Functional assessment of glutamate clearance mechanisms in a chronic rat glaucoma model using retinal ganglion cell calcium imaging. J. Neurochem. 94 3 (2005) 794-807
41. Hirakura Y., Lin M.C., and Kagan B.L. Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red. J. Neurosci. Res. 57 4 (1999) 458-466
42. Hofstra L., Dumont E.A., Thimister P.W., Heidendal G.A., DeBruine A.P., Elenbaas T.W., Boersma H.H., van Heerde W.L., and Reutelingsperger C.P. In vivo detection of apoptosis in an intracardiac tumor. JAMA 285 14 (2001) 1841-1842
43. Honkanen R.A., Baruah S., Zimmerman M.B., Khanna C.L., Weaver Y.K., Narkiewicz J., Waziri R., Gehrs K.M., Weingeist T.A., Boldt H.C., Folk J.C., Russell S.R., and Kwon Y.H. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch. Ophthalmol. 121 2 (2003) 183-188
44. Iseri P.K., Altinas O., Tokay T., and Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J. Neuroophthalmol. 26 1 (2006) 18-24
45. Johnson L.V., Leitner W.P., Rivest A.J., Staples M.K., Radeke M.J., and Anderson D.H. The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 99 18 (2002) 11830-11835
46. Kaushik S., Pandav S.S., and Ram J. Neuroprotection in glaucoma. J. Postgrad. Med. 49 1 (2003) 90-95
47. Kenis H., van Genderen H., Bennaghmouch A., Rinia H.A., Frederik P., Narula J., Hofstra L., and Reutelingsperger C.P. Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J. Biol. Chem. 279 50 (2004) 52623-52629
48. Kerrigan L., Zack D., Quigley H., Smith S.D., and Pease M. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch. Ophthalmol. 115 (1997) 1031-1035
49. Kerrigan-Baumrind L., Quigley H., Pease M., Kerrigan D., and Mitchell R. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest. Ophthalmol. Vis. Sci. 41 (2000) 741-748
50. Kietselaer B.L., Reutelingsperger C.P., Heidendal G.A., Daemen M.J., Mess W.H., Hofstra L., and Narula J. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N. Engl. J. Med. 350 14 (2004) 1472-1473
51. Kim T.W., Kim D.M., Park K.H., and Kim H. Neuroprotective effect of memantine in a rabbit model of optic nerve ischemia. Korean J. Ophthalmol. 16 1 (2002) 1-7
52. Kingston A.E., O'Neill M.J., Lam A., Bales K.R., Monn J.A., and Schoepp D.D. Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795. Eur. J. Pharmacol. 377 2-3 (1999) 155-165
53. Koh J.Y., Wie M.B., Gwag B.J., Sensi S.L., Canzoniero L.M., Demaro J., Csernansky C., and Choi D.W. Staurosporine-induced neuronal apoptosis. Exp. Neurol. 135 2 (1995) 153-159
54. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., and van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84 5 (1994) 1415-1420
55. Lagreze W.A., Knorle R., Bach M., and Feuerstein T.J. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest. Ophthalmol. Vis. Sci. 39 6 (1998) 1063-1066
56. Lee P.P., Walt J.G., Doyle J.J., Kotak S.V., Evans S.J., Budenz D.L., Chen P.P., Coleman A.L., Feldman R.M., Jampel H.D., Katz L.J., Mills R.P., Myers J.S., Noecker R.J., Piltz-Seymour J.R., Ritch R.R., Schacknow P.N., Serle J.B., and Trick G.L. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch. Ophthalmol. 124 1 (2006) 12-19
57. Levkovitch-Verbin H., Quigley H.A., Kerrigan-Baumrind L.A., D'Anna S.A., Kerrigan D., and Pease M.E. Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 42 5 (2001) 975-982
58. Levkovitch-Verbin H., Martin K.R., Quigley H.A., Baumrind L.A., Pease M.E., and Valenta D. Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection. J. Glaucoma 11 5 (2002) 396-405
59. Levkovitch-Verbin H., Quigley H.A., Martin K.R., Zack D.J., Pease M.E., and Valenta D.F. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest. Ophthalmol. Vis. Sci. 44 8 (2003) 3388-3393
60. Levy G., Kaufmann P., Buchsbaum R., Montes J., Barsdorf A., Arbing R., Battista V., Zhou X., Mitsumoto H., Levin B., and Thompson J.L. A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS. Neurology 66 5 (2006) 660-663
61. Li H.L., Roch J.M., Sundsmo M., Otero D., Sisodia S., Thomas R., and Saitoh T. Defective neurite extension is caused by a mutation in amyloid beta/A4 (A beta) protein precursor found in familial Alzheimer's disease. J. Neurobiol. 32 5 (1997) 469-480
62. Lipton S.A. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16 12 (1993) 527-532
63. Lipton S.A. Retinal ganglion cells, glaucoma and neuroprotection. Prog. Brain Res. 131 (2001) 712-718
64. Lipton S.A. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. Neurorx 1 1 (2004) 101-110
65. Lipton S.A. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. J. Alzheimers Dis. 6 6 Suppl (2004) S61-S74
66. Liu J. The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview. Neurochem. Res. (2007)
67. Lleo A., Greenberg S.M., and Growdon J.H. Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med. 57 (2006) 513-533
68. Loffler K.U., Edward D.P., and Tso M.O. Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. Invest. Ophthalmol. Vis. Sci. 36 1 (1995) 24-31
69. Lorenzo A., and Yankner B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. U.S.A. 91 25 (1994) 12243-12247
70. Lucas D.R., and Newhouse J.P. The toxic effect of sodium l-glutamate on the inner layers of the retina. AMA Arch. Ophthalmol. 58 2 (1957) 193-201
71. Maass A., von Leithner P.L., Luong V., Guo L., Salt T.E., Fitzke F.W., and Cordeiro M.F. Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes. Curr. Eye Res. 32 10 (2007) 851-861
72. Martin K.R., Levkovitch-Verbin H., Valenta D., Baumrind L., Pease M.E., and Quigley H.A. Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest. Ophthalmol. Vis. Sci. 43 7 (2002) 2236-2243
73. McCarthy S., Somayajulu M., Sikorska M., Borowy-Borowski H., and Pandey S. Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble coenzyme Q10. Toxicol. Appl. Pharmacol. 201 1 (2004) 21-31
74. McKinnon S.J., Lehman D.M., Kerrigan-Baumrind L.A., Merges C.A., Pease M.E., Kerrigan D.F., Ransom N.L., Tahzib N.G., Reitsamer H.A., Levkovitch-Verbin H., Quigley H.A., and Zack D.J. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest. Ophthalmol. Vis. Sci. 43 4 (2002) 1077-1087
75. Monn J.A., Valli M.J., Massey S.M., Wright R.A., Salhoff C.R., Johnson B.G., Howe T., Alt C.A., Rhodes G.A., Robey R.L., Griffey K.R., Tizzano J.P., Kallman M.J., Helton D.R., and Schoepp D.D. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J. Med. Chem. 40 4 (1997) 528-537
76. Murakami Y., Takamatsu H., Taki J., Tatsumi M., Noda A., Ichise R., Tait J.F., and Nishimura S. 18F-Labelled annexin V: a PET tracer for apoptosis imaging. Eur. J. Nucl. Med. Mol. Imaging 31 4 (2004) 469-474
77. Narula J., Acio E.R., Narula N., Samuels L.E., Fyfe B., Wood D., Fitzpatrick J.M., Raghunath P.N., Tomaszewski J.E., Kelly C., Steinmetz N., Green A., Tait J.F., Leppo J., Blankenberg F.G., Jain D., and Strauss H.W. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat. Med. 7 12 (2001) 1347-1352
78. Nicoletti F., Bruno V., Copani A., Casabona G., and Knopfel T. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?. Trends Neurosci. 19 7 (1996) 267-271
79. Nucci C., Tartaglione R., Cerulli A., Mancino R., Spano A., Cavaliere F., Rombola L., Bagetta G., Corasaniti M.T., and Morrone L.A. Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. Int. Rev. Neurobiol. 82 (2007) 397-406
80. Oliver J.E., Hattenhauer M.G., Herman D., Hodge D.O., Kennedy R., Fang-Yen M., and Johnson D.H. Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am. J. Ophthalmol. 133 6 (2002) 764-772
81. Osborne N.N. Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia. Vis. Neurosci. 16 1 (1999) 45-52
82. Papucci L., Schiavone N., Witort E., Donnini M., Lapucci A., Tempestini A., Formigli L., Zecchi-Orlandini S., Orlandini G., Carella G., Brancato R., and Capaccioli S. Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J. Biol. Chem. 278 30 (2003) 28220-28228
83. Parisi V., Restuccia R., Fattapposta F., Mina C., Bucci M.G., and Pierelli F. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin. Neurophysiol. 112 10 (2001) 1860-1867
84. Pastorino L., and Lu K.P. Pathogenic mechanisms in Alzheimer's disease. Eur. J. Pharmacol. 545 1 (2006) 29-38
85. Pepys M.B. Amyloidosis. Annu. Rev. Med. 57 (2006) 223-241
86. Post A.M., Katsikis P.D., Tait J.F., Geaghan S.M., Strauss H.W., and Blankenberg F.G. Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis. J. Nucl. Med. 43 10 (2002) 1359-1365
87. Quigley H.A., Nickells R.W., Kerrigan L.A., Pease M.E., Thibault D.J., and Zack D.J. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. 36 5 (1995) 774-786
88. Robbins J., Reynolds A.M., Treseder S., and Davies R. Enhancement of low-voltage-activated calcium currents by group II metabotropic glutamate receptors in rat retinal ganglion cells. Mol. Cell. Neurosci. 23 3 (2003) 341-350
89. Salt T.E., and Cordeiro M.F. Glutamate excitotoxicity in glaucoma: throwing the baby out with the bathwater?. Eye 20 6 (2006) 730-731, author reply 731-732.
90. Schuettauf F., Quinto K., Naskar R., and Zurakowski D. Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model. Vision Res. 42 20 (2002) 2333-2337
91. Shen W., and Slaughter M.M. Metabotropic and ionotropic glutamate receptors regulate calcium channel currents in salamander retinal ganglion cells. J. Physiol. 510 Pt 3 (1998) 815-828
92. Somayajulu M., McCarthy S., Hung M., Sikorska M., Borowy-Borowski H., and Pandey S. Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by coenzyme Q10. Neurobiol. Dis. 18 3 (2005) 618-627
93. Sullivan R.K., Woldemussie E., Macnab L., Ruiz G., and Pow D.V. Evoked expression of the glutamate transporter GLT-1c in retinal ganglion cells in human glaucoma and in a rat model. Invest. Ophthalmol. Vis. Sci. 47 9 (2006) 3853-3859
94. Tamura H., Kawakami H., Kanamoto T., Kato T., Yokoyama T., Sasaki K., Izumi Y., Matsumoto M., and Mishima H.K. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J. Neurol. Sci. 246 1-2 (2006) 79-83
95. Tehrani A., Wheeler-Schilling T.H., and Guenther E. Coexpression patterns of mGLuR mRNAs in rat retinal ganglion cells: a single-cell RT-PCR study. Invest. Ophthalmol. Vis. Sci. 41 1 (2000) 314-319
96. Thuret G., Chiquet C., Herrag S., Dumollard J.M., Boudard D., Bednarz J., Campos L., and Gain P. Mechanisms of staurosporine induced apoptosis in a human corneal endothelial cell line. Br. J. Ophthalmol. 87 3 (2003) 346-352
97. van de Wiele C., Lahorte C., Vermeersch H., Loose D., Mervillie K., Steinmetz N.D., Vanderheyden J.L., Cuvelier C.A., Slegers G., and Dierck R.A. Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. J. Clin. Oncol. 21 18 (2003) 3483-3487
98. Vasilevko V., and Cribbs D.H. Novel approaches for immunotherapeutic intervention in Alzheimer's disease. Neurochem. Int. 49 2 (2006) 113-126
99. Vickers J.C., Lazzarini R.A., Riederer B.M., and Morrison J.H. Intraperikaryal neurofilamentous accumulations in a subset of retinal ganglion cells in aged mice that express a human neurofilament gene. Exp. Neurol. 136 2 (1995) 266-269
100. von Ruckmann A., Fitzke F.W., and Bird A.C. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br. J. Ophthalmol. 79 5 (1995) 407-412
101. Vriens P.W., Blankenberg F.G., Stoot J.H., Ohtsuki K., Berry G.J., Tait J.F., Strauss H.W., and Robbins R.C. The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J. Thorac. Cardiovasc. Surg. 116 5 (1998) 844-853
102. Wade A.R., and Fitzke F.W. A fast, robust pattern recognition system for low light level image registration and its application to retinal imaging. Opt. Express 3 5 (1998) 190-197
103. Wamsley S., Gabelt B.T., Dahl D.B., Case G.L., Sherwood R.W., May C.A., Hernandez M.R., and Kaufman P.L. Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma. Arch. Ophthalmol. 123 1 (2005) 64-70
104. Williams A.J., Dave J.R., Lu X.M., Ling G., and Tortella F.C. Selective NR2B NMDA receptor antagonists are protective against staurosporine-induced apoptosis. Eur. J. Pharmacol. 452 1 (2002) 135-136
105. WoldeMussie E., Yoles E., Schwartz M., Ruiz G., and Wheeler L.A. Neuroprotective effect of memantine in different retinal injury models in rats. J. Glaucoma 11 6 (2002) 474-480
106. Woldemussie E., Wijono M., and Ruiz G. Muller cell response to laser-induced increase in intraocular pressure in rats. Glia 47 2 (2004) 109-119
107. Yamamoto R., Yoneda S., and Hara H. Neuroprotective effects of beta-secretase inhibitors against rat retinal ganglion cell death. Neurosci. Lett. 370 1 (2004) 61-64
108. Yoneda S., Hara H., Hirata A., Fukushima M., Inomata Y., and Tanihara H. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Jpn. J. Ophthalmol. 49 2 (2005) 106-108
109. Yucel Y.H., Gupta N., Zhang Q., Mizisin A.P., Kalichman M.W., and Weinreb R.N. Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch. Ophthalmol. 124 2 (2006) 217-225